20229
ORBO™ 52 Small Activated Silica Gel (20/40) 150/75 mg, pk 50
W,W,F separators, O.D. × L 6 mm × 75 mm, pkg of 50 ea
Synonym(s):
ORBO™ Activated Silica Gel Tube
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
47131900
NACRES:
NB.21
Quality Level
material
W,W,F separators, silica gel
agency
NIOSH 2002,2003,2004,2005,2010,2013,2014, OSHA 16,21
product line
ORBO™
composition
Bed A, 150 mg , Bed B, 75 mg
packaging
pkg of 50 ea
manufacturer/tradename
ORBO™ 52 Small
technique(s)
active air sampling: suitable
O.D. × L
6 mm × 75 mm
matrix
Activated silica gel
particle size
20-40 mesh
application(s)
air monitoring
environmental
industrial hygiene
Related Categories
General description
- ORBO™ 52 Small Activated Silica Gel (20/40) 150/75 mg solvent desorption tube is designed for gas and vapor sampling.
- It contains two beds of the same selective adsorbent separated by glass wool or foam.
- Dual-layer or two-bed construction of the tube allows for any sample breakthrough to be captured in the smaller back-up bed.
Legal Information
ORBO is a trademark of Sigma-Aldrich Co. LLC
Storage Class
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
[Explorative abrasion--obsolete?].
A Orbo
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 111(19), 2397-2398 (1991-08-20)
Anne Ørbo et al.
British journal of cancer, 115(6), 725-730 (2016-08-19)
The aim of the present study was to investigate whether changes in the tissue expression of human epididymis-specific protein 4 (HE4) could predict therapy resistance and relapse after progestin hormone therapy for medium- and low-risk endometrial hyperplasia. Endometrial biopsies were
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service